Genotypes of HBV and HCV among HIV-1 co-infected individuals in Ngong Sub-County, Kenya

Background: Hepatitis B and Hepatitis C viruses are the major causes of liver disease worldwide. Co-infections with HBV and HCV have turned out to be increasingly very common among people living with HIV, leading to a major public health concern Objective: To determine HBV and HCV diversity among HIV infected patients attending the Ngong sub-county hospital comprehensive care clinic. Design: A cross-sectional study Setting: HIV research laboratory in Centre for virus research at Kenya medical research institute, Nairobi. Subjects: HIV infected patients attending the comprehensive care clinic at Ngong subcounty hospital between May and August 2015. Results: One hundred and ninety (190) HIV-1 positive patients participated in this study, consisting of 78.9% females and 21.1% males. Out of the 190 participants, 11(5.8%) were positive for Hepatitis B surface antigen and eight (4.2%) were positive for anti- HCV antibodies. 5/11 samples were positive for HBV DNA PCR and five belonged to HBV genotype A and E . However, none of the eight samples for HCV were positive for HCV RNA PCR. Conclusion: None of the patients was infected with HCV. HBV genotype A1 was the most dominant circulating genotype in Ngong sub-County followed by genotype E. Nevertheless, there could be other HBV genotypes circulating in Kenya especially among higher risk populations.

[1]  N. Budambula,et al.  Hepatitis B virus sero-profiles and genotypes in HIV-1 infected and uninfected injection and Non-injection drug users from coastal Kenya , 2015, BMC Infectious Diseases.

[2]  R. Lihana,et al.  Characterization of HBV Among HBV/HIV-1 Co-Infected Injecting Drug Users from Mombasa, Kenya. , 2015, Current HIV research.

[3]  Christian Wejse,et al.  Hepatitis C prevalence among HIV-infected patients in Guinea-Bissau: a descriptive cross-sectional study. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[4]  R. Chauhan,et al.  Genotyping and molecular characterization of hepatitis B virus in liver disease patients in Kenya. , 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[5]  A. Nyamache,et al.  Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya , 2013, BMC Research Notes.

[6]  N. Budambula,et al.  Hepatitis B virus subgenotype A1, occurrence of subgenotype D4, and S gene mutations among voluntary blood donors in Kenya , 2013, Virus Genes.

[7]  K. Mandaliya,et al.  Prevalence, Clinical and Virologic Outcomes of Hepatitis B Virus Co-Infection in HIV-1 Positive Kenyan Women on Antiretroviral Therapy , 2013, PloS one.

[8]  J. Baeten,et al.  Immune response to hepatitis B virus vaccination among HIV-1 infected and uninfected adults in Kenya. , 2013, The Journal of infectious diseases.

[9]  M. Cabezas-Fernández,et al.  Introduction of an Automated System for the Diagnosis and Quantification of Hepatitis B and Hepatitis C Viruses , 2012, The open virology journal.

[10]  S. Chakrabarti,et al.  Occult HBV infection among anti-HBc positive HIV-infected patients in apex referral centre, Eastern India. , 2012, Annals of hepatology.

[11]  K. Ariyoshi,et al.  Chronic hepatitis B and C co-infection increased all-cause mortality in HAART-naive HIV patients in northern Thailand , 2012, Epidemiology and Infection.

[12]  G. John-Stewart,et al.  HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya , 2011, Journal of viral hepatitis.

[13]  O. Mahmoud,et al.  Prevalence of HBV genotypes among Egyptian hepatitis patients , 2011, Molecular Biology Reports.

[14]  R. Barth,et al.  Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[15]  P. Ocama,et al.  Poor performance of hepatitis C antibody tests in hospital patients in Uganda , 2010, Journal of medical virology.

[16]  F. Le Gal,et al.  A novel hepatitis B virus (HBV) subgenotype D (D8) strain, resulting from recombination between genotypes D and E, is circulating in Niger along with HBV/E strains. , 2010, The Journal of general virology.

[17]  M. Krieger,et al.  Development of Hepatitis C Virus Genotyping by Real-Time PCR Based on the NS5B Region , 2010, PloS one.

[18]  M. Arababadi,et al.  HBV-DNA in hemodialysis patients infected by HCV. , 2009, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[19]  R. Lihana,et al.  Molecular Genetic Diversity of Hepatitis B Virus in Kenya , 2009, Intervirology.

[20]  M. Fukuda,et al.  Prevalence of hepatitis C virus and its genotypes among a cohort of drug users in Kenya. , 2008, East African medical journal.

[21]  F. Brun-Vézinet,et al.  Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa , 2008, BMC infectious diseases.

[22]  Chloe Thio,et al.  Update on Hepatitis B and C , 2007 .

[23]  M. Nei,et al.  MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. , 2007, Molecular biology and evolution.

[24]  M. Alter,et al.  Epidemiology of viral hepatitis and HIV co-infection. , 2006, Journal of hepatology.

[25]  R. Ueda,et al.  Distribution of HBV genotypes among HBV carriers in Benin:phylogenetic analysis and virological characteristics of HBV genotype E. , 2005, World journal of gastroenterology.

[26]  R. Chung,et al.  Update on hepatitis B and C coinfection in HIV , 2005, Current infectious disease reports.

[27]  O. Anzala,et al.  Prevalence of HCV and HCV/HIV co-infection among in-patients at the Kenyatta National Hospital. , 2005, East African medical journal.

[28]  B. Graham,et al.  Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypes. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[29]  M. Torbenson,et al.  Occult hepatitis B. , 2002, The Lancet. Infectious diseases.

[30]  B. Schoub,et al.  Hepatitis B and C virus infections and liver function in AIDS patients at Chris Hani Baragwanath Hospital, Johannesburg. , 2009, East African medical journal.